Internship

Intern – Clinical Development

Bioinformatics

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Biotechnology
Healthcare

Compensation Overview

$19 - $55Hourly

No H1B Sponsorship

San Mateo, CA, USA

Must be able to relocate if necessary and work at the designated site for the duration of the internship.

Category
Bioinformatics
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student at an accredited U.S. based university or college enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Learning and understanding the basic knowledge of the clinical trial life cycle
  • Data visualization and analysis using machine-learning techniques and statistical methods
  • Analysis of clinical or biomarker datasets
  • Review of scientific literature for the interpretation of key findings
  • Writing analysis reports
  • Create, test, and run pipeline for analysis of clinical or biomarker datasets
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Company Stage

IPO

Total Funding

$15.9B

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with Terray Therapeutics enhances drug discovery capabilities for new treatment options.
  • Agreement with Tubulis expands Gilead's oncology portfolio, driving future revenue growth.
  • Appointment of Dietmar Berger as CMO may accelerate innovative therapy development.

What critics are saying

  • Increased competition in small-molecule therapy market may reduce competitive advantage.
  • Over-reliance on partnerships like Tubulis could strain finances if unsuccessful.
  • Leadership changes may lead to strategic shifts misaligned with company goals.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of treatments.
  • Gilead's strategic partnerships enhance its product offerings and market reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options